Your browser doesn't support javascript.
Effect of angiotensin II blockers on the prognosis of COVID-19: a toxicological view.
Shirazi, Farshad M; Banerji, Shireen; Nakhaee, Samaneh; Mehrpour, Omid.
  • Shirazi FM; Arizona Poison & Drug Information Center, University of Arizona, College of Pharmacy and University of Arizona College of Medicine, Tucson, AZ, USA.
  • Banerji S; Denver Health/Rocky Mountain Poison and Drug Safety, Denver, CO, USA.
  • Nakhaee S; Medical Toxicology and Drug Abuse Research Center (MTDRC), Birjand University of Medical Sciences, Birjand, Iran.
  • Mehrpour O; Denver Health/Rocky Mountain Poison and Drug Safety, Denver, CO, USA. omid.mehrpour@rmpdc.org.
Eur J Clin Microbiol Infect Dis ; 39(10): 2001-2002, 2020 Oct.
Article in English | MEDLINE | ID: covidwho-601457

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Pneumonia, Viral / Angiotensin-Converting Enzyme Inhibitors / Coronavirus Infections / Betacoronavirus / Cytokine Release Syndrome Type of study: Experimental Studies / Prognostic study Limits: Humans Language: English Journal: Eur J Clin Microbiol Infect Dis Journal subject: Communicable Diseases / Microbiology Year: 2020 Document Type: Article Affiliation country: S10096-020-03932-6

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Pneumonia, Viral / Angiotensin-Converting Enzyme Inhibitors / Coronavirus Infections / Betacoronavirus / Cytokine Release Syndrome Type of study: Experimental Studies / Prognostic study Limits: Humans Language: English Journal: Eur J Clin Microbiol Infect Dis Journal subject: Communicable Diseases / Microbiology Year: 2020 Document Type: Article Affiliation country: S10096-020-03932-6